Proteomics is a rapidly evolving and emerging vertical in the diagnostics domain. To help our audience get smarter on proteomics, we invited Dr. Roy Smythe, CEO of SomaLogic to share his expertise.
Dr. Smythe shares with us that, where genomics focuses on the rather static genetic make up of a patient, proteomics dials in on the proteins arising from the genetic profile. These proteins are more widely variable, can change significantly over a patient's lifetime, and can be predictive of risk in a variety of diseases.
Enjoy this episode where Dr. Smythe shares more of his real-world experience with proteomics and details a patient case where proteomics defied the highly educated medical eye to uncover a ticking time bomb of cardiovascular risk.
Proteomics is a rapidly evolving and emerging vertical in the diagnostics domain. To help our audience get smarter on proteomics, we invited Dr. Roy Smythe, CEO of SomaLogic to share his expertise.
Dr. Smythe shares with us that, where genomics focuses on the rather static genetic make up of a patient, proteomics dials in on the proteins arising from the genetic profile. These proteins are more widely variable, can change significantly over a patient's lifetime, and can be predictive of risk in a variety of diseases.
Enjoy this episode where Dr. Smythe shares more of his real-world experience with proteomics and details a patient case where proteomics defied the highly educated medical eye to uncover a ticking time bomb of cardiovascular risk.